NCT04729842View on ClinicalTrials.gov

Comparison Between Bupivacaine and Ropivacaine in Patients Undergoing Forearm Surgeries Under Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
Effect of Drug
Interventions
PROCEDURE

Axillary Brachial plexus block

Brachial plexus block via axillary route was administered using 30 ml of 0.5% Bupivacaine in group B and 30 ml of 0.5% Ropivacaine in Group R

Sponsors
All Listed Sponsors
lead

Assam Medical College

OTHER

NCT04729842 - Comparison Between Bupivacaine and Ropivacaine in Patients Undergoing Forearm Surgeries Under Brachial Plexus Block | Biotech Hunter | Biotech Hunter